Publicacions en col·laboració amb investigadors/es de Virginia Commonwealth University (11)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2023

  1. Mid-Regional Pro-Adrenomedullin and N-Terminal Pro-B-Type Natriuretic Peptide Measurement: A Multimarker Approach to Diagnosis and Prognosis in Acute Heart Failure

    Journal of Personalized Medicine, Vol. 13, Núm. 7

2021

  1. A Real-World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET-HCC

    Hepatology Communications, Vol. 5, Núm. 3, pp. 538-547

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2020

  1. Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH

    Cells, Vol. 9, Núm. 5

2019

  1. Consistency and reproducibility of next-generation sequencing in cytopathology: A second worldwide ring trial study on improved cytological molecular reference specimens

    Cancer Cytopathology, Vol. 127, Núm. 5, pp. 285-296

2010

  1. Serum total tryptase levels are increased in patients with active chronic urticaria

    Clinical and Experimental Allergy, Vol. 40, Núm. 12, pp. 1760-1766

2008

  1. Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: A practall consensus report (what the general practitioner should know about sports and allergy)

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 63, Núm. 8, pp. 953-961

2007

  1. Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-β-(1-6)- glucosamine

    Infection and Immunity, Vol. 75, Núm. 7, pp. 3406-3413

  2. Protection against Escherichia coli infection by antibody to the Staphylococcus aureus poly-N-acetylglucosamine surface polysaccharide

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, Núm. 18, pp. 7528-7533